Metals Theory for Neurodegenerative Diseases Featured at the New York Academy of Science
I attended a fascinating symposium titled "Targeting Metals in Alzheimer's and Other Neurodegenerative Diseases" at the New York Academy of Science on November 29th in NYC sponsored by our client, Prana Biotechnology (Nasdaq: PRAN) (ASX: PBT). The symposium highlighted the promise that therapies like Prana's PBT2 could offer for sufferers of neurodegenerative diseases like Alzheimer's.
Here is a link to the press release about the event:
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.